Growth hormone treatment induces mammary gland hyperplasia in aging primates

Siu T. Ng, Jian Zhou, Oluyemisi O. Adesanya, Jie Wang, Derek LeRoith, Carolyn A. Bondy

Research output: Contribution to journalArticlepeer-review

167 Scopus citations


The decline of growth hormone (GH) and insulin-like growth factor I (IGF-I) production during aging has been likened to the decrease in gonadal steroids in menopause. The repletion of GH/IGF-I levels in aging individuals is suggested to restore the lean tissue anabolism characteristic of youth. In addition to anabolic effects on musculoskeletal tissues, GH also stimulates mammary glandular growth in some species, although its effects on primate mammary growth remain unclear. Some clinical observations implicate GH in human mammary growth, for example, gynecomastia occurs in some children treated with GH (ref. 6), and tall stature and acromegaly are associated with an increased incidence of breast cancer. To investigate the effects of GH/IGF-I augmentation on mammary tissue in a model relevant to aging humans, we treated aged female rhesus monkeys with G H, IGF-I, GH + IGF-I or saline diluent for 7 weeks. IGF-I treatment was associated with a twofold increase, GH with a three- to fourfold increase, and GH + IGF-I with a four- to fivefold increase in mammary glandular size and epithelial proliferation index. These mitogenic effects were directly correlated with circulating GH and IGF-I levels, suggesting that either GH or its downstream effector IGF-I stimulates primate mammary epithelial proliferation.

Original languageEnglish
Pages (from-to)1141-1144
Number of pages4
JournalNature Medicine
Issue number10
StatePublished - Oct 1997
Externally publishedYes


Dive into the research topics of 'Growth hormone treatment induces mammary gland hyperplasia in aging primates'. Together they form a unique fingerprint.

Cite this